Related Experiment Video
Updated: Feb 28, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Abstract:
MicroRNAs (miRNAs) are noncoding small RNAs that repress protein translation by targeting specific messenger RNAs. miR-15a and miR-16-1 act as putative tumor suppressors by targeting the oncogene BCL2. These miRNAs form a cluster at the chromosomal region 13q14, which is frequently deleted in cancer. Here, we report that the miR-15a and miR-16-1 cluster targets CCND1 (encoding cyclin D1) and WNT3A, which promotes several tumorigenic features such as survival, proliferation and invasion. In cancer cells of advanced prostate tumors, the miR-15a and miR-16 level is significantly decreased, whereas the expression of BCL2, CCND1 and WNT3A is inversely upregulated. Delivery of antagomirs specific for miR-15a and miR-16 to normal mouse prostate results in marked hyperplasia, and knockdown of miR-15a and miR-16 promotes survival, proliferation and invasiveness of untransformed prostate cells, which become tumorigenic in immunodeficient NOD-SCID mice. Conversely, reconstitution of miR-15a and miR-16-1 expression results in growth arrest, apoptosis and marked regression of prostate tumor xenografts. Altogether, we propose that miR-15a and miR-16 act as tumor suppressor genes in prostate cancer through the control of cell survival, proliferation and invasion. These findings have therapeutic implications and may be exploited for future treatment of prostate cancer.
Insights
MicroRNAs miR-15a and miR-16 act as tumor suppressors in prostate cancer. Their reduced levels promote tumor growth, while restoring them inhibits cancer progression, offering therapeutic potential.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression.
- The miR-15a/miR-16-1 cluster at 13q14 is frequently deleted in cancers.
- These miRNAs are implicated as tumor suppressors targeting the BCL2 oncogene.
Purpose of the Study:
- To investigate the role of the miR-15a/miR-16-1 cluster in prostate cancer.
- To identify novel targets of miR-15a/miR-16-1 involved in tumorigenesis.
- To evaluate the therapeutic potential of restoring miR-15a/miR-16-1 expression in prostate cancer.
Main Methods:
- Target gene identification (CCND1, WNT3A) using bioinformatics and experimental validation.
- Analysis of miRNA and target gene expression in advanced prostate tumors.
- In vivo studies using antagomirs in normal mice and xenograft models.
- In vitro studies on prostate cell lines with modulated miRNA levels.
Main Results:
- miR-15a/miR-16-1 targets CCND1 and WNT3A, promoting prostate cancer survival, proliferation, and invasion.
- Prostate tumors show decreased miR-15a/miR-16 levels and increased BCL2, CCND1, and WNT3A expression.
- Inhibition of miR-15a/miR-16 promotes hyperplasia and tumorigenesis in mice.
- Restoring miR-15a/miR-16 expression induces apoptosis and tumor regression.
Conclusions:
- miR-15a and miR-16 function as tumor suppressors in prostate cancer.
- They regulate critical oncogenic pathways including cell survival, proliferation, and invasion.
- Restoration of miR-15a/miR-16 represents a potential therapeutic strategy for prostate cancer.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...
Mitogens and the Cell Cycle
MicroRNAs

